AU2001292995A1 - Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction - Google Patents
Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarctionInfo
- Publication number
- AU2001292995A1 AU2001292995A1 AU2001292995A AU9299501A AU2001292995A1 AU 2001292995 A1 AU2001292995 A1 AU 2001292995A1 AU 2001292995 A AU2001292995 A AU 2001292995A AU 9299501 A AU9299501 A AU 9299501A AU 2001292995 A1 AU2001292995 A1 AU 2001292995A1
- Authority
- AU
- Australia
- Prior art keywords
- stem cells
- myocardial infarction
- embryonic stem
- cardiac function
- therapeutic application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09684679 | 2000-10-07 | ||
US09/684,679 US6607720B1 (en) | 2000-09-05 | 2000-10-07 | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
PCT/US2001/029756 WO2002030206A1 (en) | 2000-10-07 | 2001-09-24 | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292995A1 true AU2001292995A1 (en) | 2002-04-22 |
Family
ID=24749096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292995A Abandoned AU2001292995A1 (en) | 2000-10-07 | 2001-09-24 | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
Country Status (3)
Country | Link |
---|---|
US (1) | US6607720B1 (en) |
AU (1) | AU2001292995A1 (en) |
WO (1) | WO2002030206A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6444650B1 (en) * | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
CN100506293C (en) | 2000-03-15 | 2009-07-01 | 祥丰医疗有限公司 | Coating that promotes endothelial Cell adherence |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US20030229393A1 (en) * | 2001-03-15 | 2003-12-11 | Kutryk Michael J. B. | Medical device with coating that promotes cell adherence and differentiation |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US8460367B2 (en) * | 2000-03-15 | 2013-06-11 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US20070055367A1 (en) * | 2000-03-15 | 2007-03-08 | Orbus Medical Technologies, Inc. | Medical device with coating that promotes endothelial cell adherence and differentiation |
US20070141107A1 (en) * | 2000-03-15 | 2007-06-21 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US7166280B2 (en) * | 2000-04-06 | 2007-01-23 | Franco Wayne P | Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease |
US20100303769A1 (en) * | 2000-04-06 | 2010-12-02 | Franco Wayne P | Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease |
IL159580A0 (en) | 2001-07-12 | 2004-06-01 | Geron Corp | Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
US7732199B2 (en) | 2001-07-12 | 2010-06-08 | Geron Corporation | Process for making transplantable cardiomyocytes from human embryonic stem cells |
AU2004211654B2 (en) * | 2003-02-07 | 2009-03-05 | Wisconsin Alumni Research Foundation | Directed genetic modifications of human stem cells |
US20050232905A1 (en) * | 2004-03-26 | 2005-10-20 | Yeh Edward T | Use of peripheral blood cells for cardiac regeneration |
US7452718B2 (en) | 2004-03-26 | 2008-11-18 | Geron Corporation | Direct differentiation method for making cardiomyocytes from human embryonic stem cells |
KR20070008714A (en) * | 2004-04-30 | 2007-01-17 | 오르버스네이치 메디칼 인코포레이티드 | Medical device with coating for capturing genetically-altered cells and methods of using same |
US20050277124A1 (en) * | 2004-06-10 | 2005-12-15 | White Steven M | Cardiac conduction system cells and uses thereof |
US7524490B2 (en) * | 2004-11-10 | 2009-04-28 | Board Of Regents Of The University Of Texas System | Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site |
CN103356707B (en) | 2005-03-31 | 2016-07-06 | 斯丹姆涅恩有限公司 | Prepare in order to treat wound or the ulcer of diabetic neuropathy initiation, or the method for the medicine of prevention postoperative hernia formation |
FR2884146B1 (en) * | 2005-04-07 | 2007-10-26 | Assist Publ Hopitaux De Paris | THERAPEUTIC COMPOSITIONS COMPRISING EMBRYONIC STEM CELLS |
WO2007002136A2 (en) | 2005-06-22 | 2007-01-04 | Geron Corporation | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
US20090004155A1 (en) * | 2007-02-26 | 2009-01-01 | Casey Patrick J | Method for treating a mammal having damaged myocardium tissue |
AU2009209157B2 (en) | 2008-01-30 | 2015-06-11 | Asterias Biotherapeutics, Inc. | Synthetic surfaces for culturing stem cell derived cardiomyocytes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9308271D0 (en) | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5639618A (en) | 1994-05-13 | 1997-06-17 | Plurion, Inc. | Method of isolating a lineage specific stem cell in vitro |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
-
2000
- 2000-10-07 US US09/684,679 patent/US6607720B1/en not_active Expired - Fee Related
-
2001
- 2001-09-24 AU AU2001292995A patent/AU2001292995A1/en not_active Abandoned
- 2001-09-24 WO PCT/US2001/029756 patent/WO2002030206A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002030206A1 (en) | 2002-04-18 |
US6607720B1 (en) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292995A1 (en) | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction | |
IL149387A0 (en) | Hematopoietic differentiation of human embryonic stem cells | |
AU1796601A (en) | Methods of preparing electrochemical cells | |
AU2003285172A1 (en) | Human embryonic stem cell cultures, and compositions and methods for growing same | |
IL145002A0 (en) | Adipose-derived stem cells and lattices | |
IL207008A (en) | Decellularized or synthetic tissue-s matrices comprising human placental stem cells and methods for preparation thereof | |
AU4860900A (en) | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells | |
AU2001288686A1 (en) | Improved cardiac function through administration of es cells | |
AU1741601A (en) | Mesenchymal stem cells and/or progenitor cells, their isolation and use | |
AU1478000A (en) | (in utero) transplantation of human mesenchymal stem cells | |
EP1238059A4 (en) | Long-term cell culture compositions and genetically modified animals derived therefrom | |
AU2002235168A1 (en) | Targeting pluripotent stem cells to tissues | |
AU6091600A (en) | Mammalian cells expressing desaturases and elongases | |
AU3420700A (en) | Arrangement of electrochemical cells | |
AU7437900A (en) | Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and others uses | |
AU2998300A (en) | Genetically altered mesenchymal stem cells and methods of use thereof | |
GB9916790D0 (en) | Storage of microorganisms,cells and tissue | |
AU5026600A (en) | Methods of regulating the condition of mammalian keratinous tissue | |
AU2002238218A1 (en) | Prolonged storage of red blood cells | |
AU2002309989A1 (en) | Directed evolution of protein in mammalian cells | |
AU2002220262A1 (en) | Sdf-1 beta expressing tumor cells as tumor vaccines | |
AU4774200A (en) | Long term cell culture of human carcinoma | |
AU2001237215A1 (en) | Genetically modified fibroblast cell | |
AU2001286506A1 (en) | Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells | |
AU4216200A (en) | Novel protein associated with cell stress response |